Innovative Image-Guided Programming Helps Treat Patients With Parkinson Disease
By Rafael Carbunaru, Rob Dillard - Last Updated: December 15, 2023This year, Boston Scientific received US Food and Drug Administration approval for the Vercise Neural Navigator 5 Software with STIMVIEW XT for deep brain stimulation. The software delivers simple and actionable data for efficient programming in the treatment of individuals living with Parkinson disease or essential tremor.
Advertisement
DocWire News spoke with Rafael Carbunaru, chief technology officer, neuromodulation, at Boston Scientific, about this software, which can help clinicians visualize lead placement and save time by reducing the trial and error often required to find a precise location in a patient’s brain.
Advertisement
Related Posts
Somatic comorbidities that were considered included allergies, asthma, skin diseases, and migraine, to name a few.
Dr. Anne Marie Morse elucidates how DST affects our sleep cycles and why our bodies may feel different while adjusting.
Mothers who follow a Western diet during pregnancy may have an increased risk of having children with ADHD, or autism.
Dr. Anne Marie Morse, about the significance and theme of this year’s World Sleep Day.
A novel imaging technique added to MRI allows clinicians to better tailor rehabilitation for stroke patients.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.